These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 19592461)
1. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR. de Frutos S; Nitta CH; Caldwell E; Friedman J; González Bosc LV Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L475-86. PubMed ID: 19592461 [TBL] [Abstract][Full Text] [Related]
2. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR. Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076 [TBL] [Abstract][Full Text] [Related]
3. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat. Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599 [TBL] [Abstract][Full Text] [Related]
5. Human-antigen R (HuR) expression in hypertension: downregulation of the mRNA stabilizing protein HuR in genetic hypertension. Klöss S; Rodenbach D; Bordel R; Mülsch A Hypertension; 2005 Jun; 45(6):1200-6. PubMed ID: 15883232 [TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta. Kloss S; Furneaux H; Mülsch A J Biol Chem; 2003 Jan; 278(4):2377-83. PubMed ID: 12441354 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor. Marro ML; Peiró C; Panayiotou CM; Baliga RS; Meurer S; Schmidt HH; Hobbs AJ J Biol Chem; 2008 Jul; 283(29):20027-36. PubMed ID: 18474600 [TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries. de Frutos S; Diaz JM; Nitta CH; Sherpa ML; Bosc LV Am J Physiol Cell Physiol; 2011 Aug; 301(2):C441-50. PubMed ID: 21525433 [TBL] [Abstract][Full Text] [Related]
10. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia. Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618 [TBL] [Abstract][Full Text] [Related]
11. Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia. Li D; Zhou N; Johns RA Am J Physiol; 1999 Oct; 277(4):L841-7. PubMed ID: 10516227 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species. Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839 [TBL] [Abstract][Full Text] [Related]
13. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model. Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391 [TBL] [Abstract][Full Text] [Related]
14. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries. Pearce WJ; Williams JM; White CR; Lincoln TM J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253 [TBL] [Abstract][Full Text] [Related]
15. NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal mice. Bierer R; Nitta CH; Friedman J; Codianni S; de Frutos S; Dominguez-Bautista JA; Howard TA; Resta TC; Bosc LV Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L872-80. PubMed ID: 21908592 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR. Klöss S; Srivastava R; Mülsch A Mol Pharmacol; 2004 Jun; 65(6):1440-51. PubMed ID: 15155837 [TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and characterization of alpha1-soluble guanylyl cyclase gene promoter in rat pituitary cells. Jiang Y; Stojilkovic SS J Mol Endocrinol; 2006 Dec; 37(3):503-15. PubMed ID: 17170090 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells. Bachiller PR; Nakanishi H; Roberts JD Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176 [TBL] [Abstract][Full Text] [Related]
19. α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders. Wilkins MR; Aldashev AA; Wharton J; Rhodes CJ; Vandrovcova J; Kasperaviciute D; Bhosle SG; Mueller M; Geschka S; Rison S; Kojonazarov B; Morrell NW; Neidhardt I; Surmeli NB; Aitman TJ; Stasch JP; Behrends S; Marletta MA Circ Cardiovasc Genet; 2014 Dec; 7(6):920-9. PubMed ID: 25373139 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells. Hassoun PM; Filippov G; Fogel M; Donaldson C; Kayyali US; Shimoda LA; Bloch KD Am J Respir Cell Mol Biol; 2004 Jun; 30(6):908-13. PubMed ID: 14754757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]